Cognition · single-trial review · healthy aging
Lithium
What did the mild cognitive impairment trial find?
Why the interest?
A small lithium-carbonate trial reports a favorable functional measure. Its dementia-conversion result did not reach statistical significance.
What happened in humans?
Loading scientific evidence…
Would I notice?
A change in a laboratory marker, a test score and everyday function are different outcomes. A statistically detectable result does not by itself tell us whether someone would notice a worthwhile difference.
Check the measured endpoint, comparison and study population. The full profile preserves effect estimates and the source's clinical-significance assessment, including when that assessment is not supplied.
Reality Check
The claim to test: A disease-specific result establishes a healthy-aging benefit.
What the reviewed records say:
Loading scientific evidence…
The gap: The longer follow-up had substantial attrition. Other studies and the companion safety paper still require review; findings do not establish lithium-orotate benefits.
Durability, effects in other populations and healthy-lifespan outcomes need their own evidence.
Safety and trade-offs
Loading scientific evidence…
What comes next?
Independent replication, meaningful human outcomes, longer follow-up and better safety reporting would make these results easier to interpret.
The longer follow-up had substantial attrition. Other studies and the companion safety paper still require review; findings do not establish lithium-orotate benefits.